The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Expires: July 31, 2015
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
Adicet Bio, Inc. COM NEW 007002207 155,125 22,779 SH DFND 1 0 22,779 0
Contineum Therapeutics Inc. CL A 21217B100 25,847,999 1,979,173 SH DFND 1 0 1,979,173 0
CVRx, Inc. COM 126638105 38,075,185 4,024,861 SH DFND 1 0 4,024,861 0
Fate Therapeutics, Inc. COM 31189P102 4,054,877 3,379,064 SH DFND 1 0 3,379,064 0
Legend Biotech Corporation SPONSORED ADS 52490G102 14,735,861 814,586 SH DFND 1 0 814,586 0
MeiraGTx Holdings plc COM G59665102 57,511,614 6,641,064 SH DFND 1 0 6,641,064 0
Nano-X Imaging Ltd. ORD SHS M70700105 189,668 83,554 SH DFND 1 0 83,554 0
Nanobiotix S.A. SPONSORED ADS 63009J107 173,607,200 5,623,816 SH DFND 1 0 5,623,816 0
Neumora Therapeutics, Inc. COM 640979100 3,606,418 1,849,445 SH DFND 1 0 1,849,445 0
Procept BioRobotics Corporation COM 74276L105 8,952,054 357,939 SH DFND 1 0 357,939 0
Protagonist Therapeutics Inc. COM 74366E102 258,143,888 2,449,183 SH DFND 1 0 2,449,183 0
Rallybio Corporation COM 75120L209 1,371,522 152,901 SH DFND 1 0 152,901 0
Rapport Therapeutics, Inc. COM 75383L102 55,837,537 1,784,517 SH DFND 1 0 1,784,517 0
Vor Biopharma, Inc. COM NEW 929033207 958,579 53,732 SH DFND 1 0 53,732 0
Xencor, Inc. COM 98401F105 9,021,628 748,062 SH DFND 1 0 748,062 0
Standard BioTools, Inc. COM 34385P108 286,791 311,967 SH DFND N/A 0 311,967 0